| Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
|---|
| 05/17/2000 | EP0873298A4 Chiral reductions of imines leading to the syntheses of optically active amines |
| 05/17/2000 | CN1253545A Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 05/16/2000 | US6064720 Magnetic support for removable antiscatter grid |
| 05/16/2000 | US6063145 Fuel compositions containing etheramine alkoxylates |
| 05/11/2000 | WO2000026167A1 Vitamin d analogues |
| 05/11/2000 | WO2000025767A2 Use of triphenylbutene derivatives for the treatment of neurological disorders |
| 05/10/2000 | EP0998449A1 Method for aminating mononuclear aromatic compounds and polynuclear compounds containing at least one aromatic ring in the presence of an palladium complex catalyst |
| 05/10/2000 | EP0998447A1 Tamoxifen and analogues thereof |
| 05/09/2000 | US6060625 A polyetheramine is reacted with an alkylene oxide in the presence of an alcohol catalyst to form the etheramine alkoxylate and limiting the amount of glycol by-product |
| 05/09/2000 | US6060624 Racemization of optically active alkoxyamines |
| 05/09/2000 | US6060503 Antiestrogenic, anticarcinogenic stereospecific benzopyran derivative; breast cancer |
| 05/04/2000 | WO2000024697A1 Method for preparation of polyethylene glycol aldehyde derivatives |
| 05/04/2000 | WO2000006254A3 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/03/2000 | EP0996613A1 Tramadol, salts thereof and process for their preparation |
| 05/03/2000 | EP0996432A2 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones |
| 05/03/2000 | CN1251836A Preparation of intermediate for monocyclic beta-lactams derivatives |
| 05/02/2000 | US6057476 Amination of epoxy compounds to form amino alcohols |
| 05/02/2000 | US6057371 Sigma receptor ligands and the use thereof |
| 05/02/2000 | US6057358 Amine derivatives, processes for producing them and a use of them as antiarrhythmic drugs |
| 04/27/2000 | WO2000023417A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023416A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000006137A3 Glucocorticoid-selective anti-inflammatory agents |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/26/2000 | EP0994846A1 Method for preparing 4-(alkyl)-3-alkoxy-aniline compounds |
| 04/26/2000 | EP0820459B1 Organoborane polyoxyalkylenepolyamine complexes and adhesive compositions made therewith |
| 04/26/2000 | CN1251582A Asymmetric synthesis of benzoxazinones via new intermediates |
| 04/26/2000 | CN1251571A 2-phenoxyaniline derivatives |
| 04/26/2000 | CN1251569A Noval compounds, their use and preparation |
| 04/25/2000 | US6054617 Nitro compound-reducing process |
| 04/20/2000 | WO2000021917A1 Pharmaceutical intermediate for the synthesis of fluoxetine and a process for the preparation thereof |
| 04/20/2000 | WO2000021910A2 1,2-disubstituted cyclopropanes |
| 04/20/2000 | WO2000021487A2 Formoterol polymorphs |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | DE19847231A1 Process for the production of substituted amines comprises synthesis at a solid phase having diazonium functionality |
| 04/20/2000 | CA2347092A1 1,2-disubstituted cyclopropanes |
| 04/19/2000 | EP0993440A1 Etherification reaction of an aminophenol using a phase transfer system |
| 04/19/2000 | CN1251037A Triaryl methane compounds for sickle cell disease |
| 04/18/2000 | US6051610 Compounds useful as neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics |
| 04/18/2000 | US6051056 Water-based compositions, particularly coating, ink, and agricultural compositions, manifesting reduced equilibrium and dynamic surface tension by the incorporation of a surface tension reducing amount of certain alkylated aminoether |
| 04/13/2000 | WO2000020377A1 Catalyst ligands, catalytic metal complexes and processes using same |
| 04/13/2000 | WO2000020376A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/13/2000 | CA2346363A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
| 04/12/2000 | CN1051299C Tetrahydrophthamide derivative medium for preparation of same, and herbcide which uses same as effective composition |
| 04/11/2000 | US6049007 Racemization of optically active amines |
| 04/11/2000 | US6048884 Antidiabetic agents; hypoglycemic agents |
| 04/11/2000 | US6048882 Isoprenylamine compound |
| 04/11/2000 | US6048877 Cardiovascular disorders |
| 04/11/2000 | US6048872 Dietetics; antidiabetic agents; cardiovascular disorders; gastrointestinal disorders |
| 04/06/2000 | WO2000018724A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 04/06/2000 | WO2000018723A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/06/2000 | WO2000018722A2 New derivatives of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol |
| 04/06/2000 | WO2000018721A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/06/2000 | WO1999062505A3 Method for treating neurodegenerative disorders |
| 04/06/2000 | WO1999037294A3 Mitochondria protecting agents for treating mitochondria associated diseases |
| 04/06/2000 | CA2345108A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/05/2000 | EP0990643A1 Luminescence indicator for determining calcium ions |
| 04/05/2000 | EP0990639A1 Process for producing n-cyclopropylanilines and intermediates used therefor |
| 04/05/2000 | EP0989973A1 Chalcones having antiproliferative activity |
| 04/05/2000 | EP0854856B1 Nitro compound-reducing process |
| 04/05/2000 | EP0789684B1 Process for the production of aqueous esterquat dispersions by quaternisation in the presence of dispersant mixtures |
| 04/05/2000 | EP0741689B1 Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
| 04/04/2000 | US6046362 Adding an acid or carbon dioxide to a salt of an surface active amine and naphthenic acid formed in the refining of crude oil and separating |
| 04/04/2000 | US6046361 Polyorganofullerenes |
| 04/04/2000 | CA1340948C Peptidylaminodiols |
| 04/04/2000 | CA1340940C Peptidylaminodiols |
| 03/30/2000 | WO2000017152A1 Amine derivatives and skin preparations for external use containing the same |
| 03/30/2000 | WO2000017133A2 Lta4 hydrolase inhibitors |
| 03/29/2000 | EP0988278A1 Preparation and uses of n-methylnitrone |
| 03/28/2000 | US6043359 Processes for the preparation of derivatives of 4a,5,9,10,11,12-hexahydro-6H-benzofuro-[3a,3,2-ef][2]benzazepine |
| 03/28/2000 | US6043337 Polarizable amines and polyimides for optical alignment of liquid crystals |
| 03/28/2000 | CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| 03/28/2000 | CA2109625C 3,5,3'-triiodothyronine receptor ligands |
| 03/23/2000 | WO2000015614A1 Novel compounds |
| 03/23/2000 | WO2000015601A1 Process for preparing carboxylic acids |
| 03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
| 03/23/2000 | CA2341440A1 Novel compounds |
| 03/22/2000 | EP0804537B1 Cleaning process and composition |
| 03/22/2000 | CN1247860A Preparation of high-purity E-type Tamoxifen or its citrate |
| 03/21/2000 | US6040482 Produced in a single step by reacting an oxyalkylene oxide or oxyalkylester having from 3 to 12 carbon atoms, glycidol, or a glycidyl with an aminophenol without the use of a catalyst and at low temperatures; xanthene, coumarin dyes |
| 03/21/2000 | US6040480 Preparing 2-(1,1,1-trifluoro-2-hydroxy-4-cyclopropyl-but-3-yn-2-yl),4-chloroaniline; cyclization; human immunodeficiency virus (hiv) reverse transcriptase inhibitor nontoxic maaterials; nonchromagraphic purification |
| 03/21/2000 | US6040464 Reacting a protected 1,2-dihydroxybutryamide in a hoffman rearrangement reaction mixture comprising a hypohalite, a base and solvent; chiral chemical intermediates: drugs, beta-blockers, phospholipids, liquid crystals |
| 03/21/2000 | US6040463 Sordarin derivatives |
| 03/21/2000 | US6040344 Crystalline r,r-formoterol l-(+)-tartrate. |
| 03/16/2000 | WO2000014174A1 Organic electroluminescence device and phenylenediamine derivative |
| 03/16/2000 | WO2000014173A1 Electroluminescent systems with polynuclear metal complexes |
| 03/16/2000 | WO1999063932A9 Multibinding agents that modulate the 5-ht transporter |
| 03/15/2000 | EP0984920A1 Novel method for preparing 2-trifluoro-methoxy-aniline |
| 03/14/2000 | US6037499 4,4'-bis(4-aminophenoxy),2,2',6,6'-substituted biphenyl radicals exhibiting noncoplanar conformation for enhanced solubility; polyimides made therefrom have good processability and high glass transition temperature |
| 03/09/2000 | WO2000012462A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 03/09/2000 | WO2000012461A1 Process for making 2-amino-5-cyanophenol |
| 03/09/2000 | WO2000012454A1 Novel polycationic lipids |
| 03/09/2000 | WO2000012075A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
| 03/09/2000 | DE19839946A1 Elektrolumineszierende Anordnungen mit mehrkernigen Metallkomplexen Electroluminescent arrangements with polynuclear metal complexes |
| 03/09/2000 | CA2341711A1 Process for making 2-amino-5-cyanophenol |
| 03/09/2000 | CA2341458A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 03/09/2000 | CA2339145A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
| 03/08/2000 | EP0983996A1 Cationic ortho-phenylenediamines, their use for oxidation dyeing of keratinous fibres, dyeing compositions and dyeing methods |
| 03/08/2000 | EP0983995A2 Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds |